New SEC Document(s) for Savient Pharmaceuticals

SEC Filing Alert Savient Pharmaceuticals has filed the following document(s) with the United States Securities and Exchange Commission. Feb 29, 2012 Form 10-K / Annual Report HTML PDF View all SEC Filings

You are subscribed to Savient Pharmaceuticals Investor Relations' e-mail alerts as clotito+biotechdash@gmail.com. To update your e-mail and alert preferences, please click here. To unsubscribe, please click here. Savient Pharmaceuticals One Tower Center 14th floor, East Brunswick, NJ 08816 Service provided by Shareholder.com